Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma-Reference-Cited by-同舟云学术

Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma

Author:

Davids Matthew¹,Charlton Amanda²,Ng Swee-Siang³,Chong Mei-Ling³,Laubscher Kevin⁴,Dar Mohammed⁴,Hodge Jeffrey⁴,Soong Richie³,Goh Boon Cher⁵

Affiliation:

1. Department of Haematology/Oncology, National University Health System, Singapore, Singapore

2. Department of Pathology, National University Health System, Singapore, Singapore

3. Oncology Research Institute, National University Health System, Singapore, Singapore

4. GlaxoSmithKline, Research Triangle Park, NC

5. Department of Haematology/Oncology and Oncology Research Institute, National University Health System, Singapore, Singapore

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

Reference12 articles.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献